Search Results - "Pittman, Kenneth"

Refine Results
  1. 1
  2. 2

    Multiple COVID-19 Clusters on a University Campus - North Carolina, August 2020 by Wilson, Erica, Donovan, Catherine V, Campbell, Margaret, Chai, Thevy, Pittman, Kenneth, Seña, Arlene C, Pettifor, Audrey, Weber, David J, Mallick, Aditi, Cope, Anna, Porterfield, Deborah S, Pettigrew, Erica, Moore, Zack

    “…Preventing transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), in institutes of higher education presents a unique set of…”
    Get full text
    Journal Article Newsletter
  3. 3

    A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer by Vatandoust, Sina, Joshi, Rohit, Pittman, Kenneth B., Esterman, Adrian, Broadbridge, Vy, Adams, Jacqueline, Singhal, Nimit, Yeend, Susan, Price, Timothy Jay

    Published in Supportive care in cancer (01-02-2014)
    “…Background Prolonged neurotoxicity after systemic chemotherapy has the potential to impact on quality of life. We explored the frequency of persistent…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR by Raynor, Michael P, Stephenson, Sally-Anne, Pittman, Kenneth B, Walsh, David C A, Henderson, Michael A, Dobrovic, Alexander

    Published in Journal of hematology and oncology (05-06-2009)
    “…The ability to screen blood of early stage operable breast cancer patients for circulating tumour cells is of potential importance for identifying patients at…”
    Get full text
    Journal Article
  6. 6

    Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells by Raynor, Michael, Stephenson, Sally-Anne, Walsh, David C A, Pittman, Kenneth B, Dobrovic, Alexander

    Published in BMC cancer (24-05-2002)
    “…Immunomagnetic enrichment followed by RT-PCR (immunobead RT-PCR) is an efficient methodology to identify disseminated carcinoma cells in the blood and bone…”
    Get full text
    Journal Article
  7. 7

    Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures by Pittman, Kenneth, Antill, Yoland C, Goldrick, Amanda, Goh, Jeffrey, Boer, Richard H

    Published in Asia-Pacific journal of clinical oncology (01-08-2017)
    “…Denosumab, a bone‐modifying agent, reduces the risk of skeletal‐related events in patients with bone metastases from solid tumors and is generally well…”
    Get full text
    Journal Article
  8. 8

    Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex by Knupp, C A, Shyu, W C, Dolin, R, Valentine, F T, McLaren, C, Martin, R R, Pittman, K A, Barbhaiya, R H

    Published in Clinical pharmacology and therapeutics (01-05-1991)
    “…The pharmacokinetics of didanosine (2',3'-dideoxyinosine) after intravenous and oral administration were evaluated in an open, escalating-dose phase I study in…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Pharmacokinetics of cefepime in subjects with renal insufficiency by Barbhaiya, R H, Knupp, C A, Forgue, S T, Matzke, G R, Guay, D R, Pittman, K A

    Published in Clinical pharmacology and therapeutics (01-09-1990)
    “…The pharmacokinetics of intravenously administered cefepime (1000 mg over 30 minutes) were studied in 5 healthy volunteers and 20 patients with various degrees…”
    Get more information
    Journal Article
  11. 11

    Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small-cell lung cancer: an open-label phase II multicentre trial (COVeRT study) by Singhal, Nimit, Mislang, Anna, Karapetis, Christos S, Stephens, Sonya, Borg, Martin, Woodman, Richard J, Pittman, Kenneth

    Published in Anti-cancer drugs (01-11-2015)
    “…Chemoradiotherapy regimens for stage III non-small-cell lung cancer (NSCLC) require ongoing evaluation. This South Australian multicentre prospective phase II…”
    Get full text
    Journal Article
  12. 12

    Food-induced reduction in bioavailability of didanosine by Shyu, W C, Knupp, C A, Pittman, K A, Dunkle, L, Barbhaiya, R H

    Published in Clinical pharmacology and therapeutics (01-11-1991)
    “…The effect of food on the pharmacokinetics of didanosine was evaluated in an open two-way crossover study in eight male subjects who tested seropositive for…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Denosumab for the prevention of symptomatic skeletal events in patients with castration-resistant advanced prostate cancer: A comparison with skeletal-related events by Smith, Matthew R., Coleman, Robert E., Klotz, Laurence, Pittman, Kenneth B., Milecki, Piotr, Wei, Rachel, Balakumaran, Arun, Fizazi, Karim

    Published in Journal of clinical oncology (01-02-2014)
    “…Abstract only 35 Background: In a randomized controlled trial of men with castration-resistant prostate cancer (CRPC) and bone metastases, denosumab was…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): COVeRT study by Singhal, Nimit, Pittman, Kenneth B., Karapetis, Christos Stelios, Stephens, Sonya, Borg, Martin

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only e17544 Background: Chemoradiation is standard of care for the treatment of stage III NSCLC. Vinorelbine has been widely used for the treatment in…”
    Get full text
    Journal Article
  17. 17

    Multiple-dose phase I study of transnasal butorphanol by Shyu, W C, Pittman, K A, Robinson, D, Barbhaiya, R H

    Published in Clinical pharmacology and therapeutics (01-07-1993)
    “…The safety, tolerance, and pharmacokinetics of transnasal butorphanol were evaluated in a double-blind, multiple-dose phase I study. A total of 18 subjects…”
    Get more information
    Journal Article
  18. 18

    Persistent oxaliplatin (OX) induced peripheral neuropathy in patients (pts) with colorectal cancer: A descriptive study by Vatandoust, Sina, Joshi, Rohit, Broadbridge, Vy, Pittman, Kenneth B., Adams, Jacqueline, Singhal, Nimit, Colbeck, Margaret, Yeend, Susan, Price, Timothy Jay

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only e19513 Background: Available data suggest that the OX-induced neuropathy is usually reversible and a minority of pts will have persistent severe…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Reversing Hyperammonemia in Neuroendocrine Tumors by Broadbridge, Vy, Townsend, Amanda, Pittman, Kenneth, Kimber, Richard, Patterson, William, Sukumaran, Shawgi, Price, Timothy J

    Published in Journal of clinical gastroenterology (01-09-2010)
    “…Ammonia is a neurotoxin that is normally cleared by the intact liver and if not, hyperammonemia results in hepatic encephalopathy. Hyperammonemia may be owing…”
    Get full text
    Journal Article